NM_001174096.2:c.3G>A
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1_StrongPS1_ModeratePM2PP5_Very_Strong
The NM_001174096.2(ZEB1):c.3G>A(p.Met1?) variant causes a start lost change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001174096.2 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change affects the initiator methionine of the ZEB1 mRNA. The next in-frame methionine is located at codon 219. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individuals with posterior polymorphous corneal dystrophy (PMID: 17935237, 19997581, 36613650). ClinVar contains an entry for this variant (Variation ID: 488897). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
The c.3 G>A pathogenic variant in the ZEB1 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The c.3 G>A variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. As this pathogenic variant changes the translation initiator Methionine codon, the resultant protein is described as p.Met1?, using a question mark to signify that it is not known if the loss of Met1 means that all protein translation is completely prevented or if an abnormal protein is produced using an alternate Methionine. Two other variants in the Met1 position (c.1A>G and c.2T>G) have been reported in the Human Gene Mutation Database in association with posterior polymorphous corneal dystrophy (Stenson et al., 2014). We interpret c.3 G>A as a pathogenic variant. This variant has been seen apparently de novo. -
Posterior polymorphous corneal dystrophy 3;C2750448:Corneal dystrophy, Fuchs endothelial, 6 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at